Overcoming therapeutic MAb resistance in agressive HER2 positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells - Archive ouverte HAL Access content directly
Journal Articles Journal for Immunotherapy of Cancer Year : 2013

Overcoming therapeutic MAb resistance in agressive HER2 positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells

(1) , (2) , (1) , (1) , (1) , (1) , (2)
1
2
Fichier principal
Vignette du fichier
2051-1426-1-S1-P176.pdf (140.65 Ko) Télécharger le fichier
Vignette du fichier
2051-1426-1-S1-P176.xml (4.65 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other

Dates and versions

inserm-00881032 , version 1 (07-11-2013)

Identifiers

  • HAL Id : inserm-00881032 , version 1

Cite

Sandrine Valsesia-Wittmann, Beatrice Clemenceau, Anne-Catherine Jallas, Jean-Yves Blay, Aurelien Marabelle, et al.. Overcoming therapeutic MAb resistance in agressive HER2 positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells. Journal for Immunotherapy of Cancer, 2013, 1 (Suppl 1), pp.P176. ⟨inserm-00881032⟩
167 View
186 Download

Share

Gmail Facebook Twitter LinkedIn More